Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Clinical trial NCT04997902 · COMPLETED
Trial details
- NCT number
- NCT04997902
- Sponsor
- Kura Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2025-08-29
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.